Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM)

Bronchopulmonary dysplasia (BPD) is an inflammatory disease stemming from premature birth and iatrogenic lung injury. BPD is relatively common and frequently fatal; despite this, there are no FDA-approved therapies. Montelukast is increasingly used to treat developing BPD despite scant safety and ef...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jason E. Lang, Daniel Gonzalez, Chi D. Hornik, Rachel Greenberg, Michael O'Shea, Daniel K. Benjamin, Jr., Karen Chiswell, Sophia Waymers, Matthew Laughon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-02-01
coleção:	Contemporary Clinical Trials Communications
Assuntos:	Montelukast Bronchopulmonary dysplasia Prematurity
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2451865426000165
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!